These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21197371)

  • 1. Symptom control and patient adherence to treatment: key goals in the treatment of psychosis.
    Adamou M
    Psychiatry (Edgmont); 2004 Jul; 1(1):18-9. PubMed ID: 21197371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cross-sectional observational study of healthcare professional views of factors affecting teenage adherence with antipsychotic medication.
    Ramdour S; Duxbury JA; Becket G; Wilson S
    J Psychiatr Ment Health Nurs; 2015 Sep; 22(7):491-501. PubMed ID: 25990303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosis patients' knowledge, adherence and attitudes towards the naming of antipsychotic medication in Hong Kong.
    Lau KC; Lee EH; Hui CL; Chang WC; Chan SK; Chen EY
    Early Interv Psychiatry; 2015 Oct; 9(5):422-7. PubMed ID: 25244594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boredom, dopamine, and the thrill of psychosis: psychiatry in a new key.
    Branković S
    Psychiatr Danub; 2015 Jun; 27(2):126-37. PubMed ID: 26057307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
    Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
    Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the feasibility of a decision aid to promote shared decision making among young adults with first-episode psychosis: protocol for a pilot study.
    Zisman-Ilani Y; Hurford I; Bowen A; Salzer M; Thomas EC
    Pilot Feasibility Stud; 2021 Jan; 7(1):22. PubMed ID: 33431018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCT.
    Crawford MJ; Thana L; Evans R; Carne A; O'Connell L; Claringbold A; Saravanamuthu A; Case R; Munjiza J; Jayacodi S; Reilly JG; Hughes E; Hoare Z; Barrett B; Leeson VC; Paton C; Keown P; Pappa S; Green C; Barnes TR
    Health Technol Assess; 2020 Sep; 24(44):1-54. PubMed ID: 32930090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should Antipsychotic Medications for Schizophrenia Be Given for a Lifetime?: A Naturalistic, Long-Term Follow-Up Study.
    Glick ID; Davis JM; Zamora D; Ballon J; Nuthi M
    J Clin Psychopharmacol; 2017 Apr; 37(2):125-130. PubMed ID: 28195931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis.
    Smith RC; Leucht S; Davis JM
    Psychopharmacology (Berl); 2019 Feb; 236(2):545-559. PubMed ID: 30506237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of symptom resolution on medication adherence in first episode psychosis.
    Steger KA; Cassidy C; Rabinovitch M; Joober R; Malla A
    Psychiatry Res; 2012 Mar; 196(1):45-51. PubMed ID: 22377571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for antipsychotic medication non-adherence behaviors and attitudes in adult-onset psychosis.
    Hui CLM; Poon VWY; Ko WT; Miao HY; Chang WC; Lee EHM; Chan SKW; Lin J; Chen EYH
    Schizophr Res; 2016 Jul; 174(1-3):144-149. PubMed ID: 27050476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic Treatment Failure: A Systematic Review on Risk Factors and Interventions for Treatment Adherence in Psychosis.
    El Abdellati K; De Picker L; Morrens M
    Front Neurosci; 2020; 14():531763. PubMed ID: 33162877
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment for amphetamine psychosis.
    Shoptaw SJ; Kao U; Ling W
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD003026. PubMed ID: 19160215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment for amphetamine psychosis.
    Shoptaw SJ; Kao U; Ling WW
    Cochrane Database Syst Rev; 2008 Oct; (4):CD003026. PubMed ID: 18843639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy challenges in patients with first-episode psychosis.
    Abdel-Baki A; Ouellet-Plamondon C; Malla A
    J Affect Disord; 2012; 138 Suppl():S3-14. PubMed ID: 22405590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of service-user reasons for adherence and nonadherence to neuroleptic medication in psychosis.
    Wade M; Tai S; Awenat Y; Haddock G
    Clin Psychol Rev; 2017 Feb; 51():75-95. PubMed ID: 27838461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should antipsychotic medications for schizophrenia be given for a lifetime? Replication of a naturalistic, long-term, follow-up study of antipsychotic treatment.
    Glick ID; Zamora D; Kamis D; Davis JM
    CNS Spectr; 2019 Oct; 24(5):557-563. PubMed ID: 30777584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication for psychosis--consumption and consequences: the second Australian national survey of psychosis.
    Waterreus A; Morgan VA; Castle D; Galletly C; Jablensky A; Di Prinzio P; Shah S
    Aust N Z J Psychiatry; 2012 Aug; 46(8):762-73. PubMed ID: 22689337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.